36 Recruiting Malignant Neoplasm Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceTop Recruiting Malignant Neoplasm Studies
Molecular Genetics Studies of Cancer Patients and Their Relatives
📍 Valleywise Comprehensive Health Center - Phoenix — Phoenix, Arizona
View Study & Checklist ➔Germ-Line Mutations in Blood and Saliva Samples From Patients With Cancer
📍 Jonsson Comprehensive Cancer Center — Los Angeles, California
View Study & Checklist ➔Nasal Inhalation of Isopropyl Alcohol for the Treatment of Nausea in Patients With Cancer
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Molecular Profiling in Tissue Samples From Patients With Cancer Who Are Exceptional Responders to Treatment
📍 City of Hope Comprehensive Cancer Center — Duarte, California
View Study & Checklist ➔Reproductive Health Program in Patients With Cancer
📍 Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro — Jonesboro, Arkansas
View Study & Checklist ➔rTMS in Improving Neuropathy in Patients With Stage I-IV Cancer Who Have Received Oxaliplatin Chemotherapy
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Use of a Pre-Surgical Toolkit in Improving Surgical Care and Outcomes in Older Participants With Cancer
📍 Helen F Graham Cancer Center — Newark, Delaware
View Study & Checklist ➔Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
📍 Ocean Medical Center — Brick, New Jersey
View Study & Checklist ➔Web-Based Family Outreach Program for Cancer Prevention in High-Risk Families
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
📍 University of New Mexico Comprehensive Cancer Center — Albuquerque, New Mexico
View Study & Checklist ➔A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
📍 MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
📍 Rutgers Cancer Institute of New Jersey ( Site 0052) — New Brunswick, New Jersey
View Study & Checklist ➔A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
📍 University of Iowa Hospitals ( Site 4017) — Iowa City, Iowa
View Study & Checklist ➔KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)
📍 Clermont Oncology Center ( Site 0041) — Clermont, Florida
View Study & Checklist ➔Gene and Vaccine Therapy in Treating Patients With Advanced Malignancies
📍 University of California at Los Angeles (UCLA ) — Los Angeles, California
View Study & Checklist ➔HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal Metastases
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors (MK-4884-001)
📍 NEXT Oncology ( Site 0151) — San Antonio, Texas
View Study & Checklist ➔A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
📍 Alaska Womens Cancer Care ( Site 0037) — Anchorage, Alaska
View Study & Checklist ➔Pre-operative SRS or Post-operative SRS in Treating Cancer Patients With Brain Metastases
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
📍 Childrens Hospital Los Angeles ( Site 3006) — Los Angeles, California
View Study & Checklist ➔